Skip to content

GORE EXCLUDER AAA Endoprosthesis PXT281414Recalls & reported problems

W. L. Gore & Associates, Inc. · Class 3 · Implant

All models of GORE EXCLUDER AAA Endoprosthesis (81)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
7
Deaths reported
0
Injuries reported
7
Recalls naming it
0

Summary

The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 00733132610303), received between Dec 9, 2019 and Feb 20, 2024 — classified as 7 injuries.

The most frequently reported specific device problem is “Backflow” (1 report).

2 other recalls cover devices cleared under the same FDA submission (P020004); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 1 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem5
  • Backflow1
  • Patient-Device Incompatibility1

Patient problems

  • Aneurysm6
  • Clinical Endoleak2

Recent adverse event reports

The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 20, 2024Patient-Device Incompatibility; Patient-Device Incompatibility

    THE FOLLOWING INFORMATION WAS REPORTED TO GORE: ON (B)(6) 2013, A PATIENT UNDERWENT ENDOVASCULAR TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM USING GORE® EXCLUDER® AAA ENDOPROSTHESES. A TRUNK-IPSILATERAL LEG WAS IMPLANTED INTO A LEFT LEG. A CONTRALATERAL LEG WAS IMPLANTED INTO A RIGHT LEG. THE PATIENT TOLERATED THE PROCEDURE. ON UNKNOWN DATE, A DISTAL TYPE I ENDOLEAK AT THE RIGHT LEG WAS OBSERVED. ON UNKNOWN DATE, AN ANEURYSMATIC CHANGE (ENLARGEMENT) OF A LEFT COMMON ILIAC ARTERY WAS OBSERVED. ON (B)(6) 2024, A REINTERVENTION WAS PERFORMED. AN ANGIOGRAPHY REVEALED A DISTAL TYPE I ENDOLEAK AT THE LEFT COMMON ILIAC ARTERY. ONE STENT GRAFT WAS IMPLANTED TO EXTEND DISTALLY IN THE RIGHT LEG. TWO STENT GRAFTS WERE IMPLANTED TO EXTEND DISTALLY IN THE LEFT LEG. THE DISTAL TYPE I ENDOLEAK WAS RESOLVED. THE PATIENT TOLERATED THE PROCEDURE. THE PHYSICIAN STATED THAT THESE EVENTS WERE UNAVOIDABLE BECAUSE THE STENT GRAFTS ON BOTH SIDES WERE NOT PLACED DISTALLY ENOUGH.

    Patient problems: Aneurysm; Clinical Endoleak

    MAUDE report 18744951 ↗
  • InjurySep 22, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE FOLLOWING INFORMATION WAS REPORTED TO GORE: ON (B)(6) 2013, A PATIENT UNDERWENT ENDOVASCULAR TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM (51 MM X 60 MM) AND A RIGHT COMMON ILIAC ARTERY ANEURYSM USING GORE® EXCLUDER® AAA ENDOPROSTHESES WITH COIL EMBOLIZATION OF A RIGHT INTERNAL ILIAC ARTERY. ON UNKNOWN DATE, AT A FOLLOW UP, A POSSIBLE TYPE II ENDOLEAK WAS OBSERVED. THE PHYSICIAN DECIDED TO MONITOR IT. ON (B)(6) 2018, THE PATIENT UNDERWENT ENDOVASCULAR TREATMENT OF A LEFT INTERNAL ILIAC ARTERY ANEURYSM USING A GORE® EXCLUDER® AAA ENDOPROSTHESIS WITH EMBOLIZATION OF THE LEFT INTERNAL ILIAC ARTERY AND A THORACIC AORTIC ANEURYSM USING ZENITH ALPHA. DURING THIS TREATMENT, A MINOR DIAMETER OF THE ABDOMINAL AORTIC ANEURYSM WAS 63 MM. ALSO, A POSSIBLE TYPE II ENDOLEAK WAS OBSERVED. THE PHYSICIAN DECIDED TO MONITOR IT. ON AN UNKNOWN DATE, AN ENLARGEMENT OF THE ABDOMINAL AORTIC ANEURYSM (DIAMETER WAS UNKNOWN) AND A MIGRATION OF A PROXIMAL SIDE OF THE TRUNK IPSILATERAL LEG COMPONENT WITH AN ENLARGEMENT OF THE PROXIMAL NECK WAS OBSERVED. ON (B)(6) 2022, COMPUTED TOMOGRAPHY REVEALED A MIGRATION OF THE PROXIMAL SIDE OF THE TRUNK IPSILATERAL LEG COMPONENT DISTALLY APPROXIMATELY 6 CM, AN ENLARGEM

    Patient problems: Clinical Endoleak

    MAUDE report 15466132 ↗
  • InjuryDec 7, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE FSA REPORTED: ON (B)(6) 2010, THE PATIENT WAS IMPLANTED WITH A GORE® EXCLUDER® AAA ENDOPROSTHESES TO TREAT AN ABDOMINAL AORTIC ANEURYSM. THE PATIENT TOLERATED THE PROCEDURE. IT WAS REPORTED THAT IMAGES (DATE AND MODALITY IS UNKNOWN), REVEALED A POSSIBLE PROXIMAL TYPE I ENDOLEAK. THERE IS NO ANEURYSM SAC ENLARGEMENT. IT WAS REPORTED THERE WAS A REINTERVENTION ON (B)(6) 2021. THE PHYSICIAN IMPLANTED A GORE® EXCLUDER® AAA AORTIC EXTENDER ENDOPROSTHESIS PROXIMALLY. THE ENDOLEAK WAS RESOLVED. THE PATIENT TOLERATED THE REINTERVENTION.

    Patient problems: Aneurysm

    MAUDE report 12952188 ↗
  • InjuryNov 7, 2021Backflow; Backflow

    ON (B)(6) 2008, THIS PATIENT UNDERWENT ENDOVASCULAR TREATMENT FOR AN ABDOMINAL AORTIC ANEURYSM AND WAS IMPLANTED WITH GORE® EXCLUDER® AAA ENDOPROSTHESES. THE PATIENT TOLERATED THE PROCEDURE. ON (B)(6) 2021, THE PHYSICIAN REPORTED THIS PATIENT HAS A TYPE II ENDOLEAK (SOURCE UNKNOWN) WITH ANEURYSM ENLARGEMENT (AMOUNT UNKNOWN). PATIENT IS SCHEDULED FOR AN ANGIO ON (B)(6)2021. ON (B)(6) 2021, THE PATIENT UNDERWENT REINTERVENTION TO TREAT THE TYPE II ENDOLEAK WHICH APPEARED TO ORIGINATE FROM THE LEFT INTERNAL ILIAC ARTERY (LIIA). TWO DISTAL BRANCHES WERE COILED USING PENUMBRA RUBY COIL® S VIA THE LIIA. THE PATIENT TOLERATED THE PROCEDURE AND THE ENDOLEAK WAS RESOLVED. ANEURYSM ENLARGEMENT WAS CONFIRMED HOWEVER THE AMOUNT OF ENLARGEMENT REMAINED UNKNOWN.

    Patient problems: Aneurysm

    MAUDE report 12761638 ↗
  • InjuryOct 30, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ON (B)(6) 2008, THE PATIENT WAS IMPLANTED WITH GORE® EXCLUDER® AAA ENDOPROSTHESES TO TREAT AN ABDOMINAL AORTIC ANEURYSM. IT WAS REPORTED THAT IMAGES REVEALED THE PATIENT HAD A DISTAL TYPE I ENDOLEAK (DATE AND MODALITY OF IMAGES IS UNKNOWN) IN THE LEFT COMMON ILIAC ARTERY. THERE IS ANEURYSM SAC ENLARGEMENT REPORTED (AMOUNT IS UNKNOWN). THE CAUSE FOR THE TYPE I ENDOLEAK IS UNKNOWN. THERE WAS A REINTERVENTION ON (B)(6) 2020. THE PHYSICIAN IMPLANTED A GORE® EXCLUDER® CONTRALATERAL LEG ENDOPROSTHESES BILATERALLY AND EXTENDED ALREADY IMPLANTED DEVICE IN THE RIGHT AND LEFT COMMON ILIAC ARTERIES. THE END RESULT WAS SUCCESSFUL WITH NO ENDOLEAK. THE PATIENT TOLERATED THE REINTERVENTION PROCEDURE. IT IS UNKNOWN WHICH IMPLANTED DEVICES HAD THE ENDOLEAK, THEREFORE, ALL IMPLANTED DEVICES WILL BE INCLUDED IN THIS EVENT.

    Patient problems: Aneurysm

    MAUDE report 10766871 ↗
  • InjuryApr 6, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE LEFT RENAL ARTERY WAS SNORKELED, THE RIGHT RENAL ARTERY WAS PERISCOPED.

    Patient problems: Aneurysm

    MAUDE report 9929309 ↗
  • InjuryDec 9, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ON (B)(6) 2012, THIS PATIENT UNDERWENT ENDOVASCULAR REPAIR OF AN ABDOMINAL AORTIC ANEURYSM USING GORE® EXCLUDER® AAA ENDOPROSTHESIS. THE PATIENT WAS THEN LOST TO FOLLOW UP. THE PATIENT RETURNED FOR FOLLOW UP IN (B)(6) 2017 WITH AN ANEURYSM RUPTURE AND A TYPE 1A ENDOLEAK, AND A 32MM GORE® EXCLUDER® AAA ENDOPROSTHESIS AORTIC EXTENDER COMPONENT AND ENDURANT CUFF WERE PLACED. THE PATIENT IMPROVED AFTER THE TREATMENT, HOWEVER THE ANEURYSM CONTINUED TO INCREASE DUE TO A PERSISTENT TYPE 1A ENDOLEAK. THEREFORE IN (B)(6) 2018, ENDO-ANCHORS WERE PLACED. HOWEVER, THE ANEURYSM CONTINUED TO INCREASE. IN (B)(6) 2019, THE ENDOLEAK WAS TREATED WITH GLUE AND COIL EMBOLIZATION OF THE INFERIOR MESENTERIC ARTERY. IN (B)(6) 2019, FOLLOW UP REVEALED THE ANEURYSM HAD INCREASED BY ANOTHER 3MM.

    Patient problems: Aneurysm

    MAUDE report 9438449 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P020004. One submission often covers many models, so check the product and lot details in each record.

  • Z-0996-2020 · Jan 6, 2020 · Terminated
    GORE EXCLUDER Iliac Branch Endoprosthesis (IBE)
  • Z-0995-2020 · Jan 6, 2020 · Terminated
    GORE EXCLUDER AAA Endoprosthesis

Other System, Endovascular Graft, Aortic Aneurysm Treatment devices

All System, Endovascular Graft, Aortic Aneurysm Treatment devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page